HL7.TERMINOLOGY\SpecimenAdditiveEntity

HL7 Terminology (THO)
3.0.0 - Publication

This page is part of the HL7 Terminology (v3.0.0: Release) based on FHIR R4. The current version which supercedes this version is 5.2.0. For a full list of available versions, see the Directory of published versions

ValueSet: SpecimenAdditiveEntity

Summary

Defining URL:

http://terminology.hl7.org/ValueSet/v3-SpecimenAdditiveEntity

Version:

2.0.0

Name:

SpecimenAdditiveEntity

Status:

Active as of 3/26/14

Definition:

Set of codes related to specimen additives

OID:

2.16.840.1.113883.1.11.16042 (for OID based terminology systems)

Source Resource:

XML / JSON / Turtle

References

Included into MaterialEntityClassType
Included into XBillableProduct

Logical Definition (CLD)

This value set includes codes based on the following rules:

Include codes from http://terminology.hl7.org/CodeSystem/v3-EntityCode where concept is-a _SpecimenAdditiveEntity

This value set excludes codes based on the following rules:

Exclude these codes as defined in http://terminology.hl7.org/CodeSystem/v3-EntityCode
Code Display Definition
_SpecimenAdditiveEntity SpecimenAdditiveEntity Set of codes related to specimen additives

Expansion

This value set contains 54 concepts

Expansion based on EntityCode v2.0.0 (CodeSystem)

All codes in this table are from the system http://terminology.hl7.org/CodeSystem/v3-EntityCode

Code	Display	Definition
ACDA	ACD Solution A	ACD Solution A of trisodium citrate, 22.0g/L; citric acid, 8.0 g/L; and dextrose 24.5 g/L. Used in Blood banking and histocompatibilty testing
ACDB	ACD Solution B	ACD Solution B of trisodium citrate, 13.2g/L; citric acid, 4.8 g/L; and dextrose 14.7 g/L. Used in Blood banking and histocompatibilty testing.
ACET	Acetic Acid	50% V/V acetic acid in water. Used as a urine preservative
AMIES	Amies transport medium	Sodium Chloride 3.0g, Potassium Chloride 0.2g, Calcium Chloride 0.1g, Magnesium Chloride 0.1g, Monopotassium Phosphate 0.2g, Disodium Phosphate 1.15g, Sodium Thiogly collate 1.0g, Distilled Water 1 liter
BACTM	Bacterial Transport medium	Any medium used to maintain bacterial viability (e.g. Stuart's, Cary-Blair, Amies)
BF10	Buffered 10% formalin	Formaldehyde 4% w/v; methyl alcohol 1% w/v; phosphate buffering salts. Tissue preservative
BOR	Boric Acid	Powdered boric acid (usually 10 g) added to 24-hour urine collections as a preservative.
BOUIN	Bouin's solution	Picric acid, saturated aqueous solution (750.0 ml), 37-40% formalin (250.0 ml), glacial acetic acid (50.0 ml). Tissue preservative.
BSKM	Buffered skim milk	50% skim milk in 0.01 M phosphate-buffered saline. Maintain virus viability
C32	3.2% Citrate	A 3.2% solution of Sodium Citrate in water. Used as a blood preservative
C38	3.8% Citrate	A 3.8% solution of Sodium Citrate in water. Used as a blood preservative
CARS	Carson's Modified 10% formalin	A modification of buffered 10% formalin used as a general tissue preservative.
CARY	Cary Blair Medium	Sodium Thioglycollate 1.5 g, Disodium Hydrogen Phosphate 1.1 g, Sodium Chloride 5.0 g, Calcium Chloride 0.09 g, Agar 5.0 g, per Liter of Water
CHLTM	Chlamydia transport medium	Any of a number of non-nutritive buffered media used to maintain Chlamydia viability during transportation to the laboratory
CTAD	CTAD	Buffered tri-sodium citrate solution with theophylline, adenosine and dipyridamole
EDTK15	Potassium/K EDTA 15%	Potassium EDTA 15% solution in water
EDTK75	Potassium/K EDTA 7.5%	Potassium EDTA 7.5% solution in water
EDTN	Sodium/Na EDTA	Sodium fluoride and Disodium EDTA
ENT	Enteric bacteria transport medium	Any of a number of non-nutritive buffered media used to maintain enteric bacterial viability during transportation to the laboratory
F10	10% Formalin	A 10% v/v solution in water of formalin( a 37% solution of formaldehyde and water). Used for tissue preservation.
FDP	Thrombin NIH; soybean trypsin inhibitor	Thrombin plus soybean trypsin inhibitor. For use in identifying fibrn degredation products.
FL10	Sodium Fluoride, 10mg	Sodium fluoride, 10mg added as a urine preservative.
FL100	Sodium Fluoride, 100mg	Sodium fluoride, 100mg added as a urine preservative.
HCL6	6N HCL	A solution of HCl containing 6moles of hydrogen ion/L. Used as a Urine Preservative.
HEPA	Ammonium heparin	Ammonium heparin
HEPL	Lithium/Li Heparin	Lithium heparin salt
HEPN	Sodium/Na Heparin	Sodium heparin salt
HNO3	Nitric Acid	6N Nitric acid used to preserve urine for heavy metal analysis.
JKM	Jones Kendrick Medium	A transport medium formulated to maintain Bordetella pertussis viability.
KARN	Karnovsky's fixative	5% Glutaraldehyde, 4% Formaldehyde in 0.08M buffer. Tissue preservation
KOX	Potassium Oxalate	Potassium oxalate and sodium fluoride in a 1.25:1 ratio
LIA	Lithium iodoacetate	Iodoacetate lithium salt
M4	M4	Modified Hank's balanced salt solution supplemented with bovine serum albumin, gelatin, sucrose and glutamic acid. It is buffered to pH 7.3+ or - 0.2 with HEPES buffer. Phenol red is used to indicate pH. Vancomycin, Amphotericin B and Colistin are used to
M4RT	M4-RT	Modified Hank's balanced salt solution supplemented with bovine serum albumin, gelatin, sucrose and glutamic acid. It is buffered to pH 7.3+ or - 0.2 with Hepes buffer. Phenol red is used to indicate pH. Gentamicin and amphotericin B are used to inhibit c
M5	M5	Modified Hank's balanced salt solution supplemented with protein stabilizers, sucrose and glutamic acid. It is buffered to pH 7.3+ or - 0.2 with Hepes buffer. Phenol red is used to indicate pH. Vancomycin, Amphotericin B and Colistin are used to inhibit c
MICHTM	Michel's transport medium	1M potassium citrate, pH 7.0 2.5 ml, 0.1M magnesium sulfate 5.0 ml, 0.1M N-ethyl malemide 5.0 ml, dH2O 87.5 ml, ammonium sulfate 55gm. Preserve antigens for Immunofluorescence procedures
MMDTM	MMD transport medium	A buffered medium with ammonium sulfate added to preserve antigens for Immunofluorescence procedures
NAF	Sodium Fluoride	Sodium fluoride
NONE	None	No additive. Specifically identifes the specimen as having no additives.
PAGE	Page's Saline	0.12 g NaCl, 0.004 g MgSO, 0.004 g, CaCl, 0.142 g Na2HPO4 and 0.136 g KH2PO4 per liter of distilled water. Maintain Acanthaoemba viability.
PHENOL	Phenol	Phenol. Urine preservative
PVA	Polyvinylalcohol	Polyvinyl alcohol
RLM	Reagan Lowe Medium	A transport medium formulated to maintain Bordetella pertussis viability.
SILICA	Siliceous earth	Diatomaceous earth. For glucose determination blood samples
SPS	Sodium polyanethol sulfonate 0.35% in 0.85% sodium chloride	Sodium polyanethol sulfonate in saline. Anticomplementary and antiphagocytic properties. Used in blood culture collection.
SST	Serum Separator Tube	Polymer separator gel with clot activator
STUTM	Stuart transport medium	Sodium Glycerophosphate 10.0g, Calcium Chloride 0.1g, Mercaptoacetic Acid 1.0ml, Distilled Water 1 liter
THROM	Thrombin	Thrombin. Accelerates clotting.
THYMOL	Thymol	2-Isopropyl-5-methyl phenol. A preservative for 24 Hr Urine samples
THYO	Thyoglycolate broth	A nutritive medium with a reducing agent (sodium thioglycolate) which, due to a chemical reaction, removes oxygen from the broth.
TOLU	Toluene	Also known as Methylbenzene; Toluol; Phenylmethane. A preservative for 24 Hr Urine samples
URETM	Ureaplasma transport medium	A buffered salt solution with antifungal agents added for the collection and transport of Ureaplasma specimens.
VIRTM	Viral Transport medium	Sucrose 74.6g, Potassium hydrogenphosphate 0.52g, L-glutamic acid 0.72g, Bovine serum albumin 5.0g, Gentamicin 50mg, Potassium dihydrogenphosphate 1.25g, L-15 medium 9.9L, Water to 10L. Maintain Virus viability.
WEST	Buffered Citrate	3.8% Citrate buffered to a pH of 5.5 for Westergren Sedimentation Rate

Explanation of the columns that may appear on this page:

Level

A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies

Source

The source of the definition of the code (when the value set draws in codes defined elsewhere)

Code

The code (used as the code in the resource instance)

Display

The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application

Definition

An explanation of the meaning of the concept

Comments

Additional notes about how to use the code

History

Date

Action

Custodian

Author

Comment

2020-05-06

revise